Application
NOL11 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the NOL11 antibody detected the NOL11 protein (arrow).Application
NOL11 antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the NOL11 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | NOL11 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | NOL11 Nucleolar protein 11 |
|---|---|
| Molecular Weight(MW) | 81124 Da |
| Tissue Specificity | This NOL11 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 549-578 amino acids from the C-terminal region of human NOL11. |
| Cellular Localization | Nucleus, nucleolus. |
| Entrez Gene | 25926 |
|---|---|
| Nucleotide Accession | NP_056277.2 |
Application
NOL11 Antibody (C-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the NOL11 antibody detected the NOL11 protein (arrow).
Application
NOL11 antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the NOL11 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
